The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Salmonella Infections

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Salmonella Infections


High impact information on Salmonella Infections

  • Salmonellosis: host immune responses and bacterial virulence determinants [6].
  • Sixteen percent of the isolates were resistant to ceftriaxone, the drug of choice for treating salmonellosis in children [7].
  • This nationwide outbreak of salmonellosis was most likely the result of contamination of pasteurized ice cream premix during transport in tanker trailers that had previously carried nonpasteurized liquid eggs containing S. enteritidis [8].
  • Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro [9].
  • Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo [10].

Chemical compound and disease context of Salmonella Infections


Biological context of Salmonella Infections


Anatomical context of Salmonella Infections

  • Successful resolution of salmonellosis in naive mice depends in large part upon IL-12-induced IFN-gamma production to eliminate this intracellular pathogen of macrophages [21].
  • Nontyphoidal salmonellosis is prevalent from April to October in Akita, when the mean atmospheric temperature exceeds 10 degrees C. On physical examination, 3 patients had rebound tenderness and muscle guarding on their abdominal wall; 1 of these patients underwent surgery for associated acute appendicitis [22].

Gene context of Salmonella Infections


Analytical, diagnostic and therapeutic context of Salmonella Infections


  1. Salmonellosis complicating ulcerative colitis. Treatment with trimethoprim-sulfamethoxazole. Kressner, M.S., Williams, S.E., Biempica, L., Das, K.M. JAMA (1982) [Pubmed]
  2. Different appearance of gamma delta T cells during salmonellosis between Ityr and Itys mice. Emoto, M., Naito, T., Nakamura, R., Yoshikai, Y. J. Immunol. (1993) [Pubmed]
  3. Treatment of acute bacterial diarrhea: a multicenter international trial comparing placebo with fleroxacin given as a single dose or once daily for 3 days. Butler, T., Lolekha, S., Rasidi, C., Kadio, A., del Rosal, P.L., Iskandar, H., Rubinstein, E., Pastore, G. Am. J. Med. (1993) [Pubmed]
  4. Salmonella, Campylobacter and Shigella in HIV-seropositive patients. Nelson, M.R., Shanson, D.C., Hawkins, D.A., Gazzard, B.G. AIDS (1992) [Pubmed]
  5. Cephalosporin-resistant Escherichia coli among summer camp attendees with salmonellosis. Prats, G., Mirelis, B., Miró, E., Navarro, F., Llovet, T., Johnson, J.R., Camps, N., Domínguez, A., Salleras, L. Emerging Infect. Dis. (2003) [Pubmed]
  6. Salmonellosis: host immune responses and bacterial virulence determinants. Jones, B.D., Falkow, S. Annu. Rev. Immunol. (1996) [Pubmed]
  7. The isolation of antibiotic-resistant salmonella from retail ground meats. White, D.G., Zhao, S., Sudler, R., Ayers, S., Friedman, S., Chen, S., McDermott, P.F., McDermott, S., Wagner, D.D., Meng, J. N. Engl. J. Med. (2001) [Pubmed]
  8. A national outbreak of Salmonella enteritidis infections from ice cream. The Investigation Team. Hennessy, T.W., Hedberg, C.W., Slutsker, L., White, K.E., Besser-Wiek, J.M., Moen, M.E., Feldman, J., Coleman, W.W., Edmonson, L.M., MacDonald, K.L., Osterholm, M.T. N. Engl. J. Med. (1996) [Pubmed]
  9. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. Vazquez-Torres, A., Jones-Carson, J., Mastroeni, P., Ischiropoulos, H., Fang, F.C. J. Exp. Med. (2000) [Pubmed]
  10. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. Mastroeni, P., Vazquez-Torres, A., Fang, F.C., Xu, Y., Khan, S., Hormaeche, C.E., Dougan, G. J. Exp. Med. (2000) [Pubmed]
  11. Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers. Neill, M.A., Opal, S.M., Heelan, J., Giusti, R., Cassidy, J.E., White, R., Mayer, K.H. Ann. Intern. Med. (1991) [Pubmed]
  12. Cyclooxygenase-2-mediated prostaglandin E2 production in mesenteric lymph nodes and in cultured macrophages and dendritic cells after infection with Salmonella. Bowman, C.C., Bost, K.L. J. Immunol. (2004) [Pubmed]
  13. Iron chelation via deferoxamine exacerbates experimental salmonellosis via inhibition of the nicotinamide adenine dinucleotide phosphate oxidase-dependent respiratory burst. Collins, H.L., Kaufmann, S.H., Schaible, U.E. J. Immunol. (2002) [Pubmed]
  14. Cephalosporin therapy for salmonellosis. Questions of efficacy and cross resistance with ampicillin. Cherubin, C.E., Eng, R.H., Smith, S.M., Goldstein, E.J. Arch. Intern. Med. (1986) [Pubmed]
  15. A lethal role for lipid A in Salmonella infections. Khan, S.A., Everest, P., Servos, S., Foxwell, N., Zähringer, U., Brade, H., Rietschel, E.T., Dougan, G., Charles, I.G., Maskell, D.J. Mol. Microbiol. (1998) [Pubmed]
  16. Impaired mucosal immunity in L-selectin-deficient mice orally immunized with a Salmonella vaccine vector. Pascual, D.W., White, M.D., Larson, T., Walters, N. J. Immunol. (2001) [Pubmed]
  17. Murine antibody response to oral infection with live aroA recombinant Salmonella dublin vaccine strains expressing filamentous hemagglutinin antigen from Bordetella pertussis. Molina, N.C., Parker, C.D. Infect. Immun. (1990) [Pubmed]
  18. Localization to chicken chromosome 5 of a novel locus determining salmonellosis resistance. Mariani, P., Barrow, P.A., Cheng, H.H., Groenen, M.M., Negrini, R., Bumstead, N. Immunogenetics (2001) [Pubmed]
  19. Differential effect of T-2 toxin on murine host resistance to three facultative intracellular bacterial pathogens: Listeria monocytogenes, Salmonella typhimurium, and Mycobacterium bovis. Ziprin, R.L., McMurray, D.N. Am. J. Vet. Res. (1988) [Pubmed]
  20. Norepinephrine stimulates in vitro growth but does not increase pathogenicity of Salmonella choleraesuis in an in vivo model. Nietfeld, J.C., Yeary, T.J., Basaraba, R.J., Schauenstein, K. Adv. Exp. Med. Biol. (1999) [Pubmed]
  21. Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, spantide II. Kincy-Cain, T., Bost, K.L. J. Immunol. (1996) [Pubmed]
  22. Analysis of physical and laboratory findings in nontyphoidal salmonellosis. Kayaba, H., Kodama, K., Shirayama, K., Kobayashi, Y., Adachi, T., Chihara, J. J. Infect. Chemother. (2002) [Pubmed]
  23. Th1 and Th1-inducing cytokines in Salmonella infection. Mizuno, Y., Takada, H., Nomura, A., Jin, C.H., Hattori, H., Ihara, K., Aoki, T., Eguchi, K., Hara, T. Clin. Exp. Immunol. (2003) [Pubmed]
  24. Effects of in vivo administration of anti-IL-10 monoclonal antibody on the host defence mechanism against murine Salmonella infection. Arai, T., Hiromatsu, K., Nishimura, H., Kimura, Y., Kobayashi, N., Ishida, H., Nimura, Y., Yoshikai, Y. Immunology (1995) [Pubmed]
  25. Protective effect of recombinant tumor necrosis factor-alpha in murine salmonellosis. Nakano, Y., Onozuka, K., Terada, Y., Shinomiya, H., Nakano, M. J. Immunol. (1990) [Pubmed]
  26. Differential regulation of enteric and systemic salmonellosis by slyA. Watson, P.R., Paulin, S.M., Bland, A.P., Libby, S.J., Jones, P.W., Wallis, T.S. Infect. Immun. (1999) [Pubmed]
  27. Oral immunization with an rfaH mutant elicits protection against salmonellosis in mice. Nagy, G., Dobrindt, U., Hacker, J., Emödy, L. Infect. Immun. (2004) [Pubmed]
  28. Adoptive transfer of murine host protection to salmonellosis with T-cell growth factor-dependent, Salmonella-specific T-cell lines. Paul, C., Shalala, K., Warren, R., Smith, R. Infect. Immun. (1985) [Pubmed]
  29. Effects of FK-506 on the course of murine salmonellosis. Nichterlein, T., Kretschmar, M., Geginat, G., Hirth, K., Altenburg, H.P., Hof, H. Journal of chemotherapy (Florence, Italy) (1996) [Pubmed]
  30. Norfloxacin and Salmonella excretion in acute gastroenteritis--a 6-month follow-up study. Pitkäjärvi, T., Kujanne, E., Sillantaka, I., Lumio, J. Scand. J. Infect. Dis. (1996) [Pubmed]
  31. Maturation of resistance to salmonellosis in newly hatched chicks: inhibition by cyclosporine. Ziprin, R.L., Corrier, D.E., Elissalde, M.H. Poult. Sci. (1989) [Pubmed]
  32. Influence of immunopotentiators on the antiporin immunoglobulin G subclass: distribution and protective immunity against murine salmonellosis. Nandakumar, K.S., Muthukkaruppan, V.R. Scand. J. Immunol. (1999) [Pubmed]
WikiGenes - Universities